The proposed implantable intrauterine sensor detects nitric oxide levels in real time to monitor fibrosis associated with Asherman’s Syndrome. This electrochemical, wireless-enabled device enables early diagnosis and proactive intervention, potentially transforming women's reproductive health management.
Accessibility Controls